The 8th China Pharmaceutical Innovation and Investment Conference commenced grandly on September 25, 2023, in Suzhou Industrial Park and successfully concluded on September 27th.

On the conference’s opening day, several distinguished experts in the field of biomedicine were invited to attend. Notable attendees included He Wei, Vice Chairman of the Standing Committee of the National People’s Congress and Chairman of the Chinese Peasants’ and Workers’ Democratic Party; Ding Jian, Academician of the Chinese Academy of Engineering and Dean of the School of Pharmacy at the University of Chinese Academy of Sciences; Sun Lei, Director of the Center for the Technical Evaluation of Medical Devices and Deputy Secretary of the Party Committee of the State Drug Administration; and Song Ruilin, Executive Director of the China Association for the Promotion of Pharmaceutical Innovation.

The conference focuses on the latest industrial policies, pharmaceutical R&D trends, and investment and financing trends in the pharmaceutical industry. It provides a platform for discussion, allowing both domestic and foreign pharmaceutical innovation and investment communities to actively participate and promote collaboration. Since its inception, the cumulative number of participants has exceeded 24,000 people. The conference also featured six special roadshow sessions, during which nearly 100 companies presented their projects.

META was honored to participate in this conference and was recommended to join the roadshow with its high-quality projects. Mr. Alex Wang, Head of Corporate Affairs, delivered an excellent presentation on ‘Developing New Drugs for Various Chronic Diseases Based on Immunometabolic Strategies’ on September 26th. Additionally, we engaged in valuable exchanges with authoritative experts in the biopharmaceutical industry and investment and financing experts.